Research | OneLook Acronym Finder |
Serial Number | 88982149 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Domestic Representative | Marina Dostal |
Attorney Name | Marina Dostal |
Attorney Docket Number | GRN: 618301 |
Law Office Assigned | N70 |
Employee Name | INGRAM, KYLE G |
2018-11-20 | Application Filed |
2020-10-28 | Status: Live/Pending |
2021-06-24 | Location: DIVISIONAL UNIT |
2021-06-24 | Transaction Date |
Owner: | GE Medical Systems Global Technology Company, LLC |
Address | (Trademarks: 801-4) 901 Main Avenue Norwalk DE 06851 |
Legal Entity Type | Limited Liability Company |
Legal Entity State | DE |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 9 |
U.S. Codes: | 021,023,026,036,038 |
International Codes: | 41 |
U.S. Codes: | 100,101,107 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0091 | Computer software based on artificial-intelligence AI for use in image analysis and data analysis in the medical and biotechnology fields; Computer software for use in data analysis in the medical and biotechnology fields which employs algorithms for deep learning; Computer software for collecting and analyzing data in the fields of healthcare and biotechnology; Computer software that analyzes and selects algorithms for use in predictive analytics in the field of healthcare and biotechnology; Software, firmware and hardware for use in the fields of edge computing, artificial intelligence, high performance computing, distributed computing, machine learning, automation controls, data collection, data analytics and internet of things, in the healthcare and biotechnology industries, namely, hardware and software and firmware for automating control of medical equipment and collecting and analyzing medical data; Software for information management, data collection and data analysis in the fields of asset optimization, machine diagnostics, and optimization of healthcare, hospital, laboratory and medical research processes; Computer hardware and software for medical imaging and for analysis of data gathered from a medical diagnostic apparatus to enhance clinical decision making; Computer hardware and software for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; Computer software for analyzing medical diagnostic information; Computer software for controlling and managing patient medical information; Computer software for operating patient monitoring equipment; Computer software for critical care information management; Computer software for storing, retrieving, distributing and displaying medical images and associated patient information and reports across healthcare enterprises and among healthcare providers and healthcare enterprises; Hospital and health care administrative software in the nature of software used to collect, organize, generate, modify, transmit, store and share medical records and medical bills; Computer software for automating and analyzing the administrative, financial, billing, and clinical records of healthcare organizations, providing healthcare regulatory compliance information, for capturing, distributing, managing and viewing electronic documents, for electronic data interchange EDI of healthcare transaction information, and for managing workflow in the delivery of healthcare; Computer software for use in the field of drug discovery and drug development, and pharmaceutical, biotechnology and life sciences research, namely, software for data analysis to enhance operational decision making; Computer software for managing medical laboratories in the nature of software used to collect, organize, generate, view, modify, transmit, store and share laboratory data and findings; Computer software for recording, analyzing and evaluation of medical data and medical diagnostics in the field of radiology, mammography, cardiology, anesthesia, neurology, oncology, pediatrics and electrophysiology; Computer software used to capture, store, track, report and monitor radiation levels delivered by medical devices and instruments |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2018-11-23 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-12-08 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2019-02-23 | 3 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2019-03-02 | 4 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2019-03-02 | 5 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-03-02 | 6 GNRN O:Outgoing Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2019-09-03 | 7 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2019-09-03 | 8 ARAA I:Incoming Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-09-03 | 9 TROA I:Incoming Correspondence |
ASSIGNED TO LIE | 2019-09-09 | 10 ALIE A:Allowance for Publication |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2019-09-10 | 11 CHAN I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-09-10 | 12 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-09-10 | 13 TEME I:Incoming Correspondence |
SUSPENSION LETTER WRITTEN | 2019-10-06 | 14 CNSL R:Renewal |
LETTER OF SUSPENSION E-MAILED | 2019-10-06 | 15 GNSL S: |
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2019-10-06 | 16 GNS3 O:Outgoing Correspondence |
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | 2020-04-10 | 17 RCSC S: |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-08-18 | 18 COAR I:Incoming Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-08-18 | 19 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-08-18 | 20 ARAA I:Incoming Correspondence |
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2020-08-18 | 21 ECDR I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-08-18 | 22 TCCA I:Incoming Correspondence |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-08-18 | 23 CHAN I:Incoming Correspondence |
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | 2020-10-28 | 24 RCSC S: |
TEAS REQUEST TO DIVIDE RECEIVED | 2021-04-27 | 25 ERTD I:Incoming Correspondence |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2021-05-25 | 26 AITU A:Allowance for Publication |
DIVISIONAL REQUEST RECEIVED | 2020-04-27 | 27 DRRR I:Incoming Correspondence |
DIVISIONAL PROCESSING COMPLETE | 2021-06-24 | 28 DPCC D:Assigned to Examiner |
SUSPENSION LETTER WRITTEN | 2021-07-01 | 29 CNSL R:Renewal |
LETTER OF SUSPENSION E-MAILED | 2021-07-01 | 30 GNSL S: |
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2021-07-01 | 31 GNS3 O:Outgoing Correspondence |
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2021-08-02 | 32 ERSI I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-08-09 | 33 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-08-09 | 34 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-08-16 | 35 CNSA P: |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-09-01 | 36 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2021-09-21 | 37 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-09-21 | 38 NPUB E:E-Mail |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2021-11-16 | 39 NOAM E:E-Mail |
TEAS EXTENSION RECEIVED | 2022-05-05 | 40 EEXT I:Incoming Correspondence |
SOU EXTENSION 1 FILED | 2022-05-05 | 41 EXT1 S: |
SOU EXTENSION 1 GRANTED | 2022-05-05 | 42 EX1G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-05-07 | 43 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2022-11-01 | 44 EEXT I:Incoming Correspondence |
SOU EXTENSION 2 FILED | 2022-11-01 | 45 EXT2 S: |
SOU EXTENSION 2 GRANTED | 2022-11-01 | 46 EX2G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-11-03 | 47 EXRA E:E-Mail |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2023-01-05 | 48 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2023-01-05 | 49 ARAA I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2023-01-05 | 50 TCCA I:Incoming Correspondence |
TEAS EXTENSION RECEIVED | 2023-05-16 | 51 EEXT I:Incoming Correspondence |
SOU EXTENSION 3 FILED | 2023-05-16 | 52 EXT3 S: |
SOU EXTENSION 3 GRANTED | 2023-05-16 | 53 EX3G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-05-18 | 54 EXRA E:E-Mail |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2023-10-06 | 55 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2023-10-06 | 56 ARAA I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2023-10-06 | 57 TCCA I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2023-11-06 | 58 DOCK D:Assigned to Examiner |
TEAS STATEMENT OF USE RECEIVED | 2023-11-15 | 59 EISU I:Incoming Correspondence |
USE AMENDMENT FILED | 2023-11-15 | 60 IUAF S: |
STATEMENT OF USE PROCESSING COMPLETE | 2023-11-27 | 61 SUPC I:Incoming Correspondence |
SU - NON-FINAL ACTION - WRITTEN | 2024-01-14 | 62 CNRT W: |
NON-FINAL ACTION E-MAILED | 2024-01-14 | 63 GNRT O:Outgoing Correspondence |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2024-01-14 | 64 GNRN O:Outgoing Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2024-03-14 | 65 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2024-03-14 | 66 ARAA I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2024-03-14 | 67 TCCA I:Incoming Correspondence |
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | 2024-04-12 | 68 XELR I:Incoming Correspondence |
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | 2024-04-12 | 69 XELG O:Outgoing Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.